Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease

Autor:	A. Papageorgiou, VI Bouloukos, D. P. Mikhailidis, Vasilios G. Athyros, M. Elisaf, Athanasios N. Symeonidis, AN Pehlivanidis
Rok vydání:	2004
Předmět:	Relative risk reduction Male medicine.medical_specialty Statin medicine.drug_class Atorvastatin Placebo-controlled study Angiotensin-Converting Enzyme Inhibitors Coronary Disease Hyperlipidemias Gastroenterology Internal medicine Post-hoc analysis Internal Medicine medicine Humans cardiovascular diseases Myocardial infarction Aged Hypolipidemic Agents Analysis of Variance Greece business.industry Drug Synergism Middle Aged medicine.disease Lipids Endocrinology Blood pressure Treatment Outcome ACE inhibitor Drug Therapy Combination Female business medicine.drug
Zdroj:	Journal of human hypertension. 18(11)
ISSN:	0950-9240
Popis:	We assessed the 'synergy' of statins and angiotensin-converting enzyme inhibitors (ACEI) in reducing vascular events in patients with coronary heart disease (CHD). The GREek Atorvastatin and CHD Evaluation (GREACE) Study, suggested that aggressive reduction of low density lipoprotein cholesterol to 2.59 mmol/l (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4550ee27929d56b6c090d88260c38210 https://pubmed.ncbi.nlm.nih.gov/15229622 Zobrazit plný text záznamu Plný text ve formátu PDF